Core Viewpoint - A class action securities lawsuit has been filed against TransMedics Group, Inc. for alleged securities fraud affecting investors between February 28, 2023, and January 10, 2025 [1][2]. Group 1: Allegations Against TransMedics - The lawsuit claims that TransMedics engaged in kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue [2]. - It is alleged that the company engaged in unsafe practices, concealed safety issues, and lacked proper safety oversight [2]. - The aforementioned actions reportedly increased the company's risk of scrutiny and regulatory challenges, leading to materially false and misleading statements about its business and operations [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until April 15, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit - TMDX